Novartis CEO Vas Narasimhan announced the company’s fourth quarter and 2018 full year results.
Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.
In this a16z podcast, bio general partners Jorge Conde and Vijay Pande with Sonal Chokshi interview Vas Narasimhan, CEO of Novartis, on some questions, challenges and opportunities that we’re facing in the pharma industry today.
Canavan describes how flexible working positively impacts his team.
Mittal shares how flexible working helped her and her family get through a difficult time.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.